These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25010505)

  • 1. The prognostic role of troponin I elevation after elective percutaneous coronary intervention.
    Auguadro C; Scalise F; Manfredi M; Casali V; Novelli E; Specchia G
    J Cardiovasc Med (Hagerstown); 2015 Mar; 16(3):149-55. PubMed ID: 25010505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troponin I elevation and all-cause mortality after elective percutaneous coronary interventions.
    Ferreira RM; de Souza E Silva NA; Salis LHA; da Silva RRM; Maia PD; Horta LFB; Salles EF; Nunes HMP; de Oliveira JBM; Domingues YPS; de Sousa CCM
    Cardiovasc Revasc Med; 2017 Jun; 18(4):255-260. PubMed ID: 28131744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
    Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
    Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.
    Napan S; Kashinath RC; Kadri S; Orig MN; Khadra S
    Coron Artery Dis; 2010 Aug; 21(5):261-5. PubMed ID: 20555264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final myocardial blush grade predicts troponin I elevation in unstable angina patients undergoing percutaneous intervention.
    Prasan AM; Flood C; Pitney MR; Walsh W; Jepson NS
    Heart Lung Circ; 2006 Oct; 15(5):291-6. PubMed ID: 16860603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker release after percutaneous coronary intervention in patients without established myocardial infarction as assessed by cardiac magnetic resonance with late gadolinium enhancement.
    Vieira de Melo RM; Hueb W; Nomura CH; Ribeiro da Silva EE; Villa AV; Oikawa FTC; da Costa LMA; Rezende PC; Garzillo CL; Lima EG; Franchini Ramires JA; Kalil Filho R
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):87-93. PubMed ID: 28573785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin I increase after successful percutaneous coronary angioplasty: predictors and long-term prognostic value.
    Okmen E; Cam N; Sanli A; Unal S; Tartan Z; Vural M
    Angiology; 2006; 57(2):161-9. PubMed ID: 16518523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-sensitivity cardiac troponin decrease after percutaneous coronary intervention in patients with stable coronary artery disease.
    Hamaya R; Horie T; Yonetsu T; Sugano A; Kanaji Y; Usui E; Hoshino M; Yamaguchi M; Ohya H; Sumino Y; Hada M; Hirano H; Kanno Y; Yuki H; Hirao K; Kakuta T
    Heart Vessels; 2019 Jun; 34(6):948-956. PubMed ID: 30600349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of rosuvastatin therapy on troponin I release following percutaneous coronary intervention in nonemergency patients (from the TIP 3 study).
    Veselka J; Hájek P; Tomašov P; Tesař D; Brůhová H; Matějovič M; Branny M; Studenčan M; Zemánek D
    Am J Cardiol; 2014 Feb; 113(3):446-51. PubMed ID: 24304551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of major adverse cardiovascular events and cardiac troponin-I levels following percutaneous coronary intervention: a three-year follow-up study at a single center.
    Huang ZS; Zheng ZD; Zhang JW; Tang LL; Zhou LL; Li SH; Xie XJ; Dong RM; Zhu JM; Liu JL
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3981-3992. PubMed ID: 32329875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of troponin I after elective percutaneous coronary interventions.
    Drzewiecka-Gerber A; Drzewiecki J; Wita K; Krauze J; Jaklik A; Trusz-Gluza M; Mróz I
    Kardiol Pol; 2004 Aug; 61(8):117-26; discussion 126. PubMed ID: 15457278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
    White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
    J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
    Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction evaluated by peripheral arterial tonometry is related with peak TnI values in patients with ST elevation myocardial infarction treated with primary angioplasty.
    Baptista SB; Faustino M; Simões J; Nédio M; Monteiro C; Lourenço E; Leal P; Farto eAbreu P; Gil V
    Microvasc Res; 2016 May; 105():34-9. PubMed ID: 26721522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The age, creatinine, and ejection fraction score to risk stratify patients who underwent percutaneous coronary intervention of coronary chronic total occlusion.
    Di Serafino L; Borgia F; Maeremans J; Pyxaras SA; De Bruyne B; Wijns W; Heyndrickx G; Dens J; Di Mario C; Barbato E
    Am J Cardiol; 2014 Oct; 114(8):1158-64. PubMed ID: 25152423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
    Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
    Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
    Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.
    Fan Y; Jiang Y; Fu X; Cai J; Wang Y; Li W; Gu X; Xing K; Bai S; Bi X
    Coron Artery Dis; 2015 Dec; 26(8):671-7. PubMed ID: 26267747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction.
    Piestrzeniewicz K; Luczak K; Goch JH
    Neuro Endocrinol Lett; 2008 Aug; 29(4):581-8. PubMed ID: 18766137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.